1don MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...
New respiratory research to be presented at TSANZSRS 2026 spans genomics, rare lung disease, COPD and life-course lung health. The program ...
Jerry E. Chipuk, Ph.D., has been named chair of the Department of Cellular and Molecular Medicine at FIU Medicine ...
Umoja Biopharma, Inc. (Umoja), a clinical-stage biotechnology company committed to delivering innovative and potentially curative immunotherapies for patients with cancer and autoimmune diseases, ...
Join the “New Developments in PCNSL Treatment” webinar to learn about new research, clinical trials, specialists, ...
A new study by UCLA Health published in Cell presents a major advancement in the future of personalized medicine by pinpointing new connections between people's genes, disease risk and medicine ...
Wearables data predicts patient engagement by improving models that forecast COPD patients' adherence to home pulmonary rehabilitation programs.
Pathways include an associate degree in nursing, which generally takes two or three years, or a bachelor of science in ...
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes ...
KeraX Venture Lab, the innovation arm of KeraLink International, today announced the appointment of four distinguished ...
Though TB remains the world's top infectious disease killer, there's cause for hope, Fred Hutch Cancer Center experts say.
In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results